JULIA GROSS: Open Payments
NPI 1114271970 · CLIFTON PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,001 in 103 payments from 23 companies in 2025. Trend: 2023 $1,806 · 2024 $2,053 · 2025 $2,001
Food & beverage: $2,001
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $363 |
| Teva Pharmaceuticals USA, Inc. | 16 | $279 |
| Janssen Pharmaceuticals, Inc | 6 | $168 |
| Bausch Health US, LLC | 7 | $151 |
| Novo Nordisk Inc | 6 | $143 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $120 |
| Axsome Therapeutics, Inc. | 6 | $113 |
| Neurocrine BioSciences, Inc. | 5 | $92 |
| Lilly USA, LLC | 4 | $76 |
| Astellas Pharma US Inc | 3 | $66 |
Products named: VRAYLAR, AUSTEDO XR, SPRAVATO, APLENZIN, XIFAXAN, Wegovy, INGREZZA, Auvelity.
Industry payments across NY — which companies pay providers there.
